Lung cancer is the most common cause of
cancer-related mortality worldwide. It is a complex disease involving multiple genetic and epigenetic alterations. The development of transcriptomics revealed the important role of long non-coding RNAs (lncRNAs) in
lung cancer occurrence and development. Here, microarray analysis of
lung adenocarcinoma tissues showed the abnormal expression of
lncRNA RGMB-AS1. However, the role of
lncRNA RGMB-AS1 in
lung adenocarcinoma remains largely unknown. We showed that upregulation of
lncRNA RGMB-AS1 was significantly correlated with differentiation, TNM stage, and
lymph node metastasis. In
lung adenocarcinoma cells, downregulation of
lncRNA RGMB-AS1 inhibited cell proliferation, migration, invasion, and caused cell cycle arrest at the G1/G0 phase. In vivo experiments showed that
lncRNA RGMB-AS1 downregulation significantly suppressed the growth of
lung adenocarcinoma. The expression of
lncRNA RGMB-AS1 was inversely correlated with that of repulsive guidance molecule b (RGMB) in
lung adenocarcinoma tissues, and UCSC analysis and fluorescence detection assay indicated that
lncRNA RGMB-AS1 may be involved in the development of human
lung adenocarcinoma by regulating RGMB expression though exon2 of RGMB. In summary, our findings indicate that
lncRNA RGMB-AS1 may play an important role in
lung adenocarcinoma and may serve as a potential therapeutic target.